[{"edinetCode":"E32153","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":53.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2070700.0,"sharesOwendPercent":0.7169,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":728.38,"equityRatio":0.882,"cashAndCashEquivalents":1635306000.0,"assets":2385342000.0,"currentAssets":1926596000.0,"fixedAsset":458745000.0,"tangibleFixedAssets":446718000.0,"intangibleFixedAssets":4755000.0,"investmentAndOtherAssets":7272000.0,"liabilities":281563000.0,"currentLiabilities":141690000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":56004000.0,"fixedLiabilities":139873000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":104493000.0,"netAsset":2103778000.0,"capitalStock":2103817000.0,"capital":2229186000.0,"capitalSurplus":449096000.0,"accumulatedEarnings":-574464000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-38000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":1228813000.0,"costOfSales":388833000.0,"grossProfit":839979000.0,"sgaExpenses":697822000.0,"salaryAndBenefit":115724000.0,"depreciationAndSGA":5090000.0,"RDExpenses":140642000.0,"operatingIncome":142157000.0,"nonOperatingIncome":13912000.0,"nonOperatingExpenses":22775000.0,"interestExpense":1773000.0,"ordinaryProfit":133293000.0,"extraordinaryGain":null,"extraordinaryLoss":2941000.0,"incomeBeforeTax":130352000.0,"incomeTaxes":2026000.0,"netIncome":128325000.0,"netIncomeAttributableToOwnersOfTheParentCompany":128325000.0,"comprehensiveIncome":128352000.0,"eps":44.43,"dilutedEps":44.17,"dividendPerShare":null,"per":36.3,"roe":0.0629,"cashFlowFromOperatingActivities":44828000.0,"depreciationAndCashflowFromOperatingActivities":25016000.0,"cashFlowFromInvestingActivities":98829000.0,"cashFlowFromFinancialActivities":20286000.0,"changesInCashAndCashEquivalents":144245000.0,"列1":"asr","submitDate":"2017\/6\/29","stockCode":6190,"accountingYear":"第16期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":63.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2064000.0,"sharesOwendPercent":0.7104,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":639.26,"equityRatio":0.8562,"cashAndCashEquivalents":932937000.0,"assets":2169304000.0,"currentAssets":1342839000.0,"fixedAsset":826464000.0,"tangibleFixedAssets":450493000.0,"intangibleFixedAssets":367317000.0,"investmentAndOtherAssets":8653000.0,"liabilities":311925000.0,"currentLiabilities":220833000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":56004000.0,"fixedLiabilities":91091000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":48489000.0,"netAsset":1857379000.0,"capitalStock":1865138000.0,"capital":2245242000.0,"capitalSurplus":465152000.0,"accumulatedEarnings":-845256000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-7759000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":902366000.0,"costOfSales":396632000.0,"grossProfit":505733000.0,"sgaExpenses":774352000.0,"salaryAndBenefit":130334000.0,"depreciationAndSGA":5610000.0,"RDExpenses":176120000.0,"operatingIncome":-268618000.0,"nonOperatingIncome":3727000.0,"nonOperatingExpenses":2337000.0,"interestExpense":1657000.0,"ordinaryProfit":-267227000.0,"extraordinaryGain":null,"extraordinaryLoss":108000.0,"incomeBeforeTax":-267336000.0,"incomeTaxes":3454000.0,"netIncome":-270791000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-270791000.0,"comprehensiveIncome":-278512000.0,"eps":-93.36,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-187197000.0,"depreciationAndCashflowFromOperatingActivities":24432000.0,"cashFlowFromInvestingActivities":-451611000.0,"cashFlowFromFinancialActivities":-62995000.0,"changesInCashAndCashEquivalents":-702369000.0,"列1":"asr","submitDate":"2018\/6\/29","stockCode":6190,"accountingYear":"第17期（自　平成29年４月１日　至　平成30年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":72.0,"averageTemporaryStaff":8.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2063300.0,"sharesOwendPercent":0.706,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":527.82,"equityRatio":0.8097,"cashAndCashEquivalents":656689000.0,"assets":1905299000.0,"currentAssets":1135002000.0,"fixedAsset":770296000.0,"tangibleFixedAssets":470035000.0,"intangibleFixedAssets":288443000.0,"investmentAndOtherAssets":11817000.0,"liabilities":362643000.0,"currentLiabilities":304383000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":26004000.0,"fixedLiabilities":58259000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":22485000.0,"netAsset":1542655000.0,"capitalStock":1584856000.0,"capital":2253851000.0,"capitalSurplus":473760000.0,"accumulatedEarnings":-1142755000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-42200000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":1228363000.0,"costOfSales":377018000.0,"grossProfit":851344000.0,"sgaExpenses":1163279000.0,"salaryAndBenefit":206175000.0,"depreciationAndSGA":9748000.0,"RDExpenses":345585000.0,"operatingIncome":-311934000.0,"nonOperatingIncome":34265000.0,"nonOperatingExpenses":2015000.0,"interestExpense":1403000.0,"ordinaryProfit":-279684000.0,"extraordinaryGain":null,"extraordinaryLoss":15466000.0,"incomeBeforeTax":-295150000.0,"incomeTaxes":2348000.0,"netIncome":-297499000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-297499000.0,"comprehensiveIncome":-331940000.0,"eps":-101.96,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-159534000.0,"depreciationAndCashflowFromOperatingActivities":30083000.0,"cashFlowFromInvestingActivities":-64625000.0,"cashFlowFromFinancialActivities":-64743000.0,"changesInCashAndCashEquivalents":-276248000.0,"列1":"asr","submitDate":"2019\/6\/28","stockCode":6190,"accountingYear":"第18期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.765,"cashAndCashEquivalents":null,"assets":1918683000.0,"currentAssets":1059833000.0,"fixedAsset":858849000.0,"tangibleFixedAssets":562845000.0,"intangibleFixedAssets":283874000.0,"investmentAndOtherAssets":12130000.0,"liabilities":451817000.0,"currentLiabilities":333177000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":20004000.0,"fixedLiabilities":118639000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":17484000.0,"netAsset":1466866000.0,"capitalStock":1506204000.0,"capital":2253851000.0,"capitalSurplus":473760000.0,"accumulatedEarnings":-1221366000.0,"treasuryStock":-40000.0,"valuationAndConversionAdjustments":-39338000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":288831000.0,"costOfSales":103292000.0,"grossProfit":185538000.0,"sgaExpenses":267528000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":-81989000.0,"nonOperatingIncome":8185000.0,"nonOperatingExpenses":4203000.0,"interestExpense":283000.0,"ordinaryProfit":-78008000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-78008000.0,"incomeTaxes":602000.0,"netIncome":-78611000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-78611000.0,"comprehensiveIncome":-75748000.0,"eps":-26.9,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":6190,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2072321.0,"sharesOwendPercent":0.7063,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.723,"cashAndCashEquivalents":655466000.0,"assets":1935560000.0,"currentAssets":1098382000.0,"fixedAsset":837177000.0,"tangibleFixedAssets":550780000.0,"intangibleFixedAssets":274388000.0,"investmentAndOtherAssets":12008000.0,"liabilities":536404000.0,"currentLiabilities":428772000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":20004000.0,"fixedLiabilities":107632000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12483000.0,"netAsset":1399155000.0,"capitalStock":1438889000.0,"capital":2259264000.0,"capitalSurplus":479173000.0,"accumulatedEarnings":-1299507000.0,"treasuryStock":-40000.0,"valuationAndConversionAdjustments":-39734000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":521862000.0,"costOfSales":180611000.0,"grossProfit":341250000.0,"sgaExpenses":506290000.0,"salaryAndBenefit":110971000.0,"depreciationAndSGA":4884000.0,"RDExpenses":105579000.0,"operatingIncome":-165039000.0,"nonOperatingIncome":15962000.0,"nonOperatingExpenses":6360000.0,"interestExpense":549000.0,"ordinaryProfit":-155437000.0,"extraordinaryGain":null,"extraordinaryLoss":109000.0,"incomeBeforeTax":-155546000.0,"incomeTaxes":1205000.0,"netIncome":-156752000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-156752000.0,"comprehensiveIncome":-154285000.0,"eps":-53.54,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":34327000.0,"depreciationAndCashflowFromOperatingActivities":25673000.0,"cashFlowFromInvestingActivities":-757000.0,"cashFlowFromFinancialActivities":-30023000.0,"changesInCashAndCashEquivalents":-1223000.0,"列1":"q2r","submitDate":"2019\/11\/14","stockCode":6190,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.668,"cashAndCashEquivalents":null,"assets":2044625000.0,"currentAssets":1227321000.0,"fixedAsset":817304000.0,"tangibleFixedAssets":542018000.0,"intangibleFixedAssets":263272000.0,"investmentAndOtherAssets":12013000.0,"liabilities":678311000.0,"currentLiabilities":581733000.0,"shorTermDept":200000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":20004000.0,"fixedLiabilities":96578000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":7482000.0,"netAsset":1366313000.0,"capitalStock":1410733000.0,"capital":2259264000.0,"capitalSurplus":479173000.0,"accumulatedEarnings":-1327663000.0,"treasuryStock":-40000.0,"valuationAndConversionAdjustments":-44419000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":833042000.0,"costOfSales":283059000.0,"grossProfit":549983000.0,"sgaExpenses":750020000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":-200036000.0,"nonOperatingIncome":21151000.0,"nonOperatingExpenses":4105000.0,"interestExpense":1086000.0,"ordinaryProfit":-182991000.0,"extraordinaryGain":null,"extraordinaryLoss":109000.0,"incomeBeforeTax":-183100000.0,"incomeTaxes":1807000.0,"netIncome":-184907000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-184907000.0,"comprehensiveIncome":-187127000.0,"eps":-63.11,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/14","stockCode":6190,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":71.0,"averageTemporaryStaff":8.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2058700.0,"sharesOwendPercent":0.7017,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":395.69,"equityRatio":0.417,"cashAndCashEquivalents":1775429000.0,"assets":2784325000.0,"currentAssets":2257308000.0,"fixedAsset":527016000.0,"tangibleFixedAssets":507975000.0,"intangibleFixedAssets":2861000.0,"investmentAndOtherAssets":16179000.0,"liabilities":1622480000.0,"currentLiabilities":534917000.0,"shorTermDept":200000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":20004000.0,"fixedLiabilities":1087562000.0,"bonds":null,"convertibleBond":1000000000.0,"commercialPaper":null,"longTermDebts":2481000.0,"netAsset":1161844000.0,"capitalStock":1179926000.0,"capital":2259264000.0,"capitalSurplus":479173000.0,"accumulatedEarnings":-1558471000.0,"treasuryStock":-40000.0,"valuationAndConversionAdjustments":-18995000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":1310861000.0,"costOfSales":444751000.0,"grossProfit":866109000.0,"sgaExpenses":1012746000.0,"salaryAndBenefit":215106000.0,"depreciationAndSGA":9997000.0,"RDExpenses":238378000.0,"operatingIncome":-146637000.0,"nonOperatingIncome":39788000.0,"nonOperatingExpenses":18498000.0,"interestExpense":1544000.0,"ordinaryProfit":-125346000.0,"extraordinaryGain":null,"extraordinaryLoss":292231000.0,"incomeBeforeTax":-417578000.0,"incomeTaxes":-1863000.0,"netIncome":-415715000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-415715000.0,"comprehensiveIncome":-392510000.0,"eps":-141.84,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-12617000.0,"depreciationAndCashflowFromOperatingActivities":53291000.0,"cashFlowFromInvestingActivities":-15754000.0,"cashFlowFromFinancialActivities":1146053000.0,"changesInCashAndCashEquivalents":1118740000.0,"列1":"asr","submitDate":"2020\/6\/26","stockCode":6190,"accountingYear":"第19期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.475,"cashAndCashEquivalents":null,"assets":2521011000.0,"currentAssets":1936095000.0,"fixedAsset":584915000.0,"tangibleFixedAssets":566756000.0,"intangibleFixedAssets":2521000.0,"investmentAndOtherAssets":15638000.0,"liabilities":1322317000.0,"currentLiabilities":342179000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":17484000.0,"fixedLiabilities":980138000.0,"bonds":null,"convertibleBond":900000000.0,"commercialPaper":null,"longTermDebts":null,"netAsset":1198694000.0,"capitalStock":1242883000.0,"capital":2351624000.0,"capitalSurplus":571533000.0,"accumulatedEarnings":-1680234000.0,"treasuryStock":-40000.0,"valuationAndConversionAdjustments":-44948000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":162424000.0,"costOfSales":70522000.0,"grossProfit":91902000.0,"sgaExpenses":225185000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":-133283000.0,"nonOperatingIncome":12591000.0,"nonOperatingExpenses":469000.0,"interestExpense":469000.0,"ordinaryProfit":-121161000.0,"extraordinaryGain":null,"extraordinaryLoss":0.0,"incomeBeforeTax":-121161000.0,"incomeTaxes":602000.0,"netIncome":-121763000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-121763000.0,"comprehensiveIncome":-147716000.0,"eps":-39.64,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/12","stockCode":6190,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2068000.0,"sharesOwendPercent":0.6289,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.444,"cashAndCashEquivalents":1415543000.0,"assets":2410417000.0,"currentAssets":1770800000.0,"fixedAsset":639617000.0,"tangibleFixedAssets":621251000.0,"intangibleFixedAssets":2724000.0,"investmentAndOtherAssets":15640000.0,"liabilities":1340582000.0,"currentLiabilities":364944000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":12483000.0,"fixedLiabilities":975638000.0,"bonds":null,"convertibleBond":900000000.0,"commercialPaper":null,"longTermDebts":null,"netAsset":1069834000.0,"capitalStock":1110599000.0,"capital":2358126000.0,"capitalSurplus":578035000.0,"accumulatedEarnings":-1825521000.0,"treasuryStock":-40000.0,"valuationAndConversionAdjustments":-41524000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":301698000.0,"costOfSales":144893000.0,"grossProfit":156804000.0,"sgaExpenses":445802000.0,"salaryAndBenefit":108060000.0,"depreciationAndSGA":4006000.0,"RDExpenses":115755000.0,"operatingIncome":-288997000.0,"nonOperatingIncome":24474000.0,"nonOperatingExpenses":1322000.0,"interestExpense":730000.0,"ordinaryProfit":-265845000.0,"extraordinaryGain":null,"extraordinaryLoss":0.0,"incomeBeforeTax":-265845000.0,"incomeTaxes":1204000.0,"netIncome":-267050000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-267050000.0,"comprehensiveIncome":-289579000.0,"eps":-83.98,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-79162000.0,"depreciationAndCashflowFromOperatingActivities":19410000.0,"cashFlowFromInvestingActivities":-130152000.0,"cashFlowFromFinancialActivities":-137201000.0,"changesInCashAndCashEquivalents":-359886000.0,"列1":"q2r","submitDate":"2020\/11\/13","stockCode":6190,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.408,"cashAndCashEquivalents":null,"assets":2401908000.0,"currentAssets":1735869000.0,"fixedAsset":666039000.0,"tangibleFixedAssets":653514000.0,"intangibleFixedAssets":2356000.0,"investmentAndOtherAssets":10168000.0,"liabilities":1421130000.0,"currentLiabilities":447385000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":7482000.0,"fixedLiabilities":973745000.0,"bonds":null,"convertibleBond":900000000.0,"commercialPaper":null,"longTermDebts":null,"netAsset":980777000.0,"capitalStock":1030326000.0,"capital":2358126000.0,"capitalSurplus":578035000.0,"accumulatedEarnings":-1905794000.0,"treasuryStock":-40000.0,"valuationAndConversionAdjustments":-50308000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":501205000.0,"costOfSales":213896000.0,"grossProfit":287308000.0,"sgaExpenses":651123000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":-363815000.0,"nonOperatingIncome":28022000.0,"nonOperatingExpenses":1113000.0,"interestExpense":977000.0,"ordinaryProfit":-336905000.0,"extraordinaryGain":null,"extraordinaryLoss":0.0,"incomeBeforeTax":-336905000.0,"incomeTaxes":10417000.0,"netIncome":-347323000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-347323000.0,"comprehensiveIncome":-378636000.0,"eps":-108.0,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/12","stockCode":6190,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":69.0,"averageTemporaryStaff":10.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2096800.0,"sharesOwendPercent":0.6377,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":332.47,"equityRatio":0.4345,"cashAndCashEquivalents":1327813000.0,"assets":2516324000.0,"currentAssets":1799414000.0,"fixedAsset":716910000.0,"tangibleFixedAssets":702222000.0,"intangibleFixedAssets":2580000.0,"investmentAndOtherAssets":12108000.0,"liabilities":1422334000.0,"currentLiabilities":398784000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2481000.0,"fixedLiabilities":1023549000.0,"bonds":null,"convertibleBond":900000000.0,"commercialPaper":null,"longTermDebts":null,"netAsset":1093990000.0,"capitalStock":1139647000.0,"capital":2358126000.0,"capitalSurplus":578035000.0,"accumulatedEarnings":-1796473000.0,"treasuryStock":-40000.0,"valuationAndConversionAdjustments":-46416000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":1013543000.0,"costOfSales":425402000.0,"grossProfit":588140000.0,"sgaExpenses":865030000.0,"salaryAndBenefit":206898000.0,"depreciationAndSGA":8622000.0,"RDExpenses":221115000.0,"operatingIncome":-276889000.0,"nonOperatingIncome":54316000.0,"nonOperatingExpenses":1302000.0,"interestExpense":1167000.0,"ordinaryProfit":-223875000.0,"extraordinaryGain":null,"extraordinaryLoss":0.0,"incomeBeforeTax":-223875000.0,"incomeTaxes":14126000.0,"netIncome":-238002000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-238002000.0,"comprehensiveIncome":-265423000.0,"eps":-73.6,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-101909000.0,"depreciationAndCashflowFromOperatingActivities":55442000.0,"cashFlowFromInvestingActivities":-184775000.0,"cashFlowFromFinancialActivities":-160194000.0,"changesInCashAndCashEquivalents":-447616000.0,"列1":"asr","submitDate":"2021\/6\/25","stockCode":6190,"accountingYear":"第20期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.482,"cashAndCashEquivalents":null,"assets":2603598000.0,"currentAssets":1863680000.0,"fixedAsset":739918000.0,"tangibleFixedAssets":725713000.0,"intangibleFixedAssets":2313000.0,"investmentAndOtherAssets":11891000.0,"liabilities":1348393000.0,"currentLiabilities":315235000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1033157000.0,"bonds":null,"convertibleBond":900000000.0,"commercialPaper":null,"longTermDebts":null,"netAsset":1255205000.0,"capitalStock":1285085000.0,"capital":2358126000.0,"capitalSurplus":578035000.0,"accumulatedEarnings":-1651035000.0,"treasuryStock":-40000.0,"valuationAndConversionAdjustments":-30640000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":452049000.0,"costOfSales":164968000.0,"grossProfit":287081000.0,"sgaExpenses":217268000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":69812000.0,"nonOperatingIncome":4271000.0,"nonOperatingExpenses":182000.0,"interestExpense":182000.0,"ordinaryProfit":73901000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":73901000.0,"incomeTaxes":9145000.0,"netIncome":64755000.0,"netIncomeAttributableToOwnersOfTheParentCompany":64755000.0,"comprehensiveIncome":80532000.0,"eps":19.69,"dilutedEps":12.91,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/13","stockCode":6190,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2052800.0,"sharesOwendPercent":0.6207,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.422,"cashAndCashEquivalents":1299022000.0,"assets":2563367000.0,"currentAssets":1837246000.0,"fixedAsset":726120000.0,"tangibleFixedAssets":712495000.0,"intangibleFixedAssets":2046000.0,"investmentAndOtherAssets":11577000.0,"liabilities":1480951000.0,"currentLiabilities":446532000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1034418000.0,"bonds":null,"convertibleBond":900000000.0,"commercialPaper":null,"longTermDebts":null,"netAsset":1082416000.0,"capitalStock":1101458000.0,"capital":2363956000.0,"capitalSurplus":583866000.0,"accumulatedEarnings":-1846324000.0,"treasuryStock":-40000.0,"valuationAndConversionAdjustments":-19801000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":637912000.0,"costOfSales":347957000.0,"grossProfit":289955000.0,"sgaExpenses":423155000.0,"salaryAndBenefit":106608000.0,"depreciationAndSGA":5772000.0,"RDExpenses":89081000.0,"operatingIncome":-133200000.0,"nonOperatingIncome":4968000.0,"nonOperatingExpenses":557000.0,"interestExpense":450000.0,"ordinaryProfit":-128788000.0,"extraordinaryGain":null,"extraordinaryLoss":9000.0,"incomeBeforeTax":-128798000.0,"incomeTaxes":1734000.0,"netIncome":-130533000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-130533000.0,"comprehensiveIncome":-103918000.0,"eps":-39.59,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-10706000.0,"depreciationAndCashflowFromOperatingActivities":42341000.0,"cashFlowFromInvestingActivities":-5203000.0,"cashFlowFromFinancialActivities":-19064000.0,"changesInCashAndCashEquivalents":-28790000.0,"列1":"q2r","submitDate":"2021\/11\/12","stockCode":6190,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0},{"edinetCode":"E32153","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.416,"cashAndCashEquivalents":null,"assets":2513774000.0,"currentAssets":1812808000.0,"fixedAsset":700966000.0,"tangibleFixedAssets":687969000.0,"intangibleFixedAssets":1780000.0,"investmentAndOtherAssets":11216000.0,"liabilities":1465048000.0,"currentLiabilities":440243000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1024804000.0,"bonds":null,"convertibleBond":900000000.0,"commercialPaper":null,"longTermDebts":null,"netAsset":1048726000.0,"capitalStock":1070231000.0,"capital":2363956000.0,"capitalSurplus":583866000.0,"accumulatedEarnings":-1877550000.0,"treasuryStock":-40000.0,"valuationAndConversionAdjustments":-24152000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":933150000.0,"costOfSales":469166000.0,"grossProfit":463983000.0,"sgaExpenses":636217000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":-172233000.0,"nonOperatingIncome":14152000.0,"nonOperatingExpenses":814000.0,"interestExpense":704000.0,"ordinaryProfit":-158895000.0,"extraordinaryGain":null,"extraordinaryLoss":9000.0,"incomeBeforeTax":-158904000.0,"incomeTaxes":2854000.0,"netIncome":-161759000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-161759000.0,"comprehensiveIncome":-139495000.0,"eps":-49.01,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/14","stockCode":6190,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32153","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2259,"settlementDate":"2022\/3\/31","submitterName":"株式会社フェニックスバイオ","submitterNameEnglish":"PhoenixBio Co.,Ltd.","submitterNameKana":"カブシキガイシャフェニックスバイオ","location":"東広島市鏡山三丁目４番１号","industory":"サービス業","corporateNumber":3240000000000.0}]